4.6 Article

Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Ovarian Cancer Clinical Trial Breakthroughs and Impact on Management

Rebecca Ann Previs et al.

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2019)

Article Multidisciplinary Sciences

Vasohibins/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation

Chrystelle Aillaud et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

Vasohibins encode tubulin detyrosinating activity

Joppe Nieuwenhuis et al.

SCIENCE (2017)

Review Biochemistry & Molecular Biology

Development and Applications of CRISPR-Cas9 for Genome Engineering

Patrick D. Hsu et al.

Article Oncology

Cancer Statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Article Multidisciplinary Sciences

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jinek et al.

SCIENCE (2012)

Article Oncology

Recent advances in systemic treatments for ovarian cancer

Susana Banerjee et al.

CANCER IMAGING (2012)

Article Cell Biology

Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion

Yasuhiro Suzuki et al.

JOURNAL OF CELL SCIENCE (2010)

Article Biochemistry & Molecular Biology

Autocrine VEGF signaling is required for vascular homeostasis

Sunyoung Lee et al.

Review Medicine, General & Internal

Cancer of the ovary

SA Cannistra

NEW ENGLAND JOURNAL OF MEDICINE (2004)